 Theravance Biopharma Inc NASDAQ: TBPH revealed results from the second Phase 3 study assessing ampreloxetine compared to placebo for symptomatic nOH. Neurogenic orthostatic hypotension nOH is a rare disorder defined as a sustained orthostatic fall in blood pressure within. 